We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Relationships of Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor Expression to Clinical Outcomes in Patients with Colorectal Cancer.
- Authors
Takahari, Daisuke; Yamada, Yasuhide; Okita, Natuko T.; Honda, Takuya; Hirashima, Yoshinori; Matsubara, Junichi; Takashima, Atsuo; Kato, Ken; Hamaguchi, Tetsuya; Shirao, Kuniaki; Shimada, Yasuhiro; Shimoda, Tadakazu
- Abstract
Objectives: The present study evaluated the prognostic implications of insulin-like growth factor-1 receptor (IGF-1R), epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER)-2 in patients with colorectal cancer (CRC). Methods: Our subjects were 91 patients who underwent surgery and subsequently received fluoropyrimidines. Expressions of IGF-1R, EGFR and HER-2 in primary lesions were analyzed immunohistochemically to determine the prognostic significance of these biomarkers. Results: Overexpression was found for IGF-1R in 48 tumors (53%), EGFR in 57 (63%) and HER-2 in 2 (2%). Overexpression of IGF-1R was significantly correlated with shorter survival from the start of first-line chemotherapy (p = 0.033). Overexpression of EGFR was a significant predictor of clinical response to fluoropyrimidines (p = 0.032). Multivariate analysis of potential prognostic factors showed that IGF-1R expression and worsened performance status were independent predictors of poor outcomes. Conclusions: Our results suggest that anti-IGF-1R strategies may offer a useful approach in molecular therapy for CRC, which has the potential to improve outcomes. Copyright © 2008 S. Karger AG, Basel
- Subjects
SOMATOMEDIN; GROWTH factors; EPIDERMAL growth factor; COLON cancer patients; LARGE intestine
- Publication
Oncology, 2009, Vol 76, Issue 1, p42
- ISSN
0030-2414
- Publication type
Article
- DOI
10.1159/000178164